Expert Review of Clinical Pharmacology
Impact Factor Trend (2018–2026)
Clarivate IF trend for Expert Review of Clinical Pharmacology
SCImago Journal Rank citation prestige weighting
73 papers with at least that number of citations each
Aims & Scope
Advances in drug development technologies are yielding innovative new therapies, from potentially lifesaving medicines to lifestyle products. In recent years, however, the cost of developing new drugs has soared, and concerns over drug resistance and pharmacoeconomics have come to the fore. Adverse reactions experienced at the clinical trial level serve as a constant reminder of the importance of rigorous safety and toxicity testing. Furthermore the advent of pharmacogenomics and ‘individualized’ approaches to therapy will demand a fresh approach to drug evaluation and healthcare delivery. Clinical Pharmacology provides an essential role in integrating the expertise of all of the specialists and players who are active in meeting such challenges in modern biomedical practice.
Special Issues
Calls for PapersNo active Calls for Papers found for this journal.
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
PHARMACOLOGY & PHARMACY
PHARMACOLOGY & PHARMACY
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Journal Metrics & Citation Visualizations
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Academic Intelligence Overview & Context
ImpaQ AnalysisExpert Review of Clinical Pharmacology (acronym: erf, abbr: Expert Rev. Clin. Pharmacol, ISSN: 1751-2433) is a peer-reviewed international scholarly journal in the field of PHARMACOLOGY & PHARMACY, published by Taylor and Francis Ltd. in England. The periodical holds a Journal Impact Factor (JIF) of 3.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.848 (Q1), an H-index of 73.
The journal enforces rigorous peer evaluation with an annual output of approximately 112 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,292 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics